期刊文献+

sIL-2R在急性移植物抗宿主病中的临床研究 被引量:1

Effect Of sIL-2R On Acute Graft-Versus-Host Disease
下载PDF
导出
摘要 目的探讨细胞因子sIL-2R在异基因造血干细胞移植(allo-HSCT)后急性移植物抗宿主病(aGVHD)发病机理中的作用。方法观察20例Allo-HSCT患者aGVHD的发病情况,移植前后定期采集20例患者的外周血,采用双夹心酶联免疫吸附法(ELISA)检测其细胞因子sIL-2R的浓度。结果①异基因造血干细胞移植后20例患者全部获得造血功能重建,中性粒细胞恢复到0.5×109/L及血小板恢复到20×109/L的中位时间分别为移植后13.5d及18d;②发生aGVHD的患者,sIL-2R浓度较移植前明显升高,sIL-2R浓度在aGVHD阳性组明显高于aGVHD阴性组(P<0.01)。结论①细胞因子sIL-2R在aGVHD的发病中起重要的正向调节作用,检测异基因造血干细胞移植后患者血清的sIL-2R水平有助于预测aGVHD的发生;②sIL-2R与感染无相关性。 Objective To study the effect of cytokine sIL-2R on acute graft-versus-host disease (aGVHD) after allogeneic hemopoietic stem cell transplantation(allo-HSCT). Methods The aGVHD was observed in 20 patients with AIIo-HSCT. The peripheral blood of 20 patients was collected before and after transplantion, the concentration of sIL-2R was detected by enzyme-linked immunosorbentassay (ELISA). Results The haematogenesis of 20 patients recovered after the allogeneic hemopoietic stem cell transplantation. The median-time that neutrophilic granulocyte recovered to 0. 5 × 109/L was 13.5 days, the median-time that platelet recovered to 20 × 109/L was 18 days. The concentration of sIL-2R in patients with aGVHD significantly in- creased more than that in patients without aGVHD ( P 〈 0. O1 ), Conclusions sIL-2R has the up-regulated function in Agvhd. It' s valuable to detect the concentration of sIL-2R after transplantation for predicting aGVHD.
出处 《中国现代药物应用》 2009年第13期15-17,共3页 Chinese Journal of Modern Drug Application
关键词 细胞因子 急性移植物杭宿主病 异基因造血干细胞移植 Cytokine Acute Graft-Versus-Host Disease Allogeneic Hemopoietic Stem Cell Trans-plantation
  • 相关文献

参考文献11

  • 1Slavin S, NaglerA, Naparstek E,et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventionalbone marrow transplantation with lethal eytoreduction for the treatment of malignantand nonmalignanthematologic diseases. Blood, 1998 ; 91 : 756-758.
  • 2GlucksbergH, StorbR, FeferA, etal. Clinical manifestations of graftversus-host disease in human recipients of marrow from HLA-match sibling donors. Transplantation, 1974,18:295-304.
  • 3Garderet L, Snell V, Przepiorka D, et al. Effective depletion of alloreaetive lymphecytes from peripheral blood mononuclear cell preparations. Transplantation, 1999, 67 : 124-130.
  • 4Harris DT, Sakiestewa D, Lyons C, et al. Prevention of graft-versus-host disease by elimination of recipent-reactive donor T cells with recombinant toxin that target the interleukin 2 (sIL-2R) receptor.
  • 5Grimm J, Zeller W, Zander AR, et al. Soluble interleukin- 2receptor serum levels after allogeneie bone marrow transplantation as a marker for GVHD. Bone Marrow Transplant, 1998, 21: 29-32.
  • 6Grimm J, ZeUerW, ZanderAR,et al. Soluble interleukin-2 recetor serum levels after allogeneie bonemarrow transplantation as amarker forGVHD. BoneMarrow Transplant, 1998; 21: 29-32.
  • 7王书红,达万明,靳海杰,靖域,颜光涛.急性移植物抗宿主病病人血清IL-2、IL-8、IL-10及TNF-α水平变化的研究[J].中国实验血液学杂志,2006,14(4):755-758. 被引量:10
  • 8夏凌辉,江汇娟,方峻,刘芳,刘仲萍.多种细胞因子与急性移植物抗宿主病发病关系的研究[J].临床血液学杂志,2006,19(2):90-91. 被引量:8
  • 9武小娟,李春富,唐湘凤,石磊.IL-11在大鼠→小鼠异种骨髓移植中对急性GVHD的预防作用[J].现代免疫学,2005,25(1):28-32. 被引量:6
  • 10徐敏,丁慧芳,耿丽,路希敬.IL-18与急性移植物抗宿主病的关系[J].免疫学杂志,2005,21(6):504-506. 被引量:5

二级参考文献38

  • 1陈萍,张云志,赵海涛,孙丽,马晓锋,迟秀丽,马壮.抗CD86单克隆抗体对哮喘小鼠T_(H1)T_(H2)细胞因子的影响[J].免疫学杂志,2004,20(6):456-458. 被引量:1
  • 2李新,孙万军,原野,毛宁,艾辉胜.小鼠H-2单倍相合非清髓骨髓移植后细胞因子表达的动态研究[J].中国实验血液学杂志,2005,13(4):687-691. 被引量:3
  • 3Teshima T, Hill GR, Pan L, et al. IL-11 separates graft-versusleukemia effects from graft-versus-host disease after bone marrow transplantation [J] . J Clin Invest, 1999,104:317-325.
  • 4Cooke KR, Kobzik L, Martin TR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin[J] . Blood,1996,88:3230-3239.
  • 5Reddy P, Ferrara JL. Immunobiology of acute graft-versus-host disease[J]. Blood Rev, 2003,17(4):187-194.
  • 6Opal SM, Keith JC, Palardy JE, et al. Recombinant human interleukin -11 has anti-inflammatory actions yet does not exacerbate systemic Listeria infection[J]. J Infect Dis, 2000,181 (2):754-756.
  • 7Shimizu T, Shiratori K, Sawada T,et al. Recombinant human interleukin-11 decreases severity of acute necrotizing pancreatitis in mice[J]. Pancreas, 2000,21 (2):134-140.
  • 8Venkova K, Keith JC Jr, van Meerveld GB. Oral treatment with recombinant human interleukin-11 improves mucosal transport in the colon of human leukocyte antigen-B27 transgenic rats [J] . J Pharmacol Exp Ther, 2004,308 ( 1 ) :206-213.
  • 9Opal SM, Jhung JW, Keith JC Jr, et al. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis [J]. Blood, 1999,93(10):3467-3472.
  • 10van der Meeren A, Mouthon MA, Gaugler MH, et al. Administration of recombinant human IL-11 after supralethal radiation exposure promotes survival in mice: interactive effect with thrombopoietin[J]. Radiat Res, 2002,157(6):642-649.

共引文献12

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部